| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeffrey Trigilio | Chief Financial Officer | 2026-04-13 | 1,632 | $36.76 | $59.99kSell |
| Joseph M. Limber | Director | 2026-03-27 | 3,026 | $11.20 | $33.89kBuy |
| Jack L. Wyszomierski | Director | 2026-03-24 | 3,026 | $11.20 | $33.89kBuy |
| Owen Hughes | Chief Executive Officer | 2025-12-04 | 100,000 | $25.05 | $2.51MBuy |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.81 | $552.15Sell |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.93 | $553.95Sell |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 4,300 | $35.98 | $154.71kSell |
| Bradley Sitko | Chief Investment Officer | 2025-06-30 | 2,000 | $25.39 | $50.78kBuy |
| Owen Hughes | Chief Executive Officer | 2025-05-20 | 25,637 | $25.38 | $650.67kSell |
| Thomas M. Burns | SVP Finance CFO | 2025-05-20 | 10,482 | $25.38 | $266.03kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Brothers Life Sciences Capital GP LLC | 114.28% | 13,606,093 | $569.96M | Insider |
| Baker Brothers Life Sciences LP | 114.28% | 13,606,093 | $569.96M | Insider |
| Bvf Inc | 21.76% | 2,590,303 | $108.51M | Institution |
| Morgan Stanley | 14.40% | 1,714,668 | $71.83M | Institution |
| 667 LP | 13.32% | 1,585,591 | $66.42M | Insider |
| Baker Biotech Capital GP LLC | 13.32% | 1,585,591 | $66.42M | Insider |
| Bvf Partners L P | 10.65% | 1,267,545 | $53.10M | Insider |
| Fmr LLC | 9.76% | 1,161,889 | $48.67M | Institution |
| Bvf GP Holdings LLC | 9.27% | 1,103,314 | $46.22M | Insider |
| Vanguard Group Inc | 5.89% | 701,657 | $29.39M | Institution |